HLN
Haleon plc
NYSE: HLN · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$9.24
-0.65% today
Updated 2026-04-30
Market cap
$42.18B
P/E ratio
18.98
P/S ratio
3.82x
EPS (TTM)
$0.50
Dividend yield
0.74%
52W range
$9 – $11
Volume
8.4M
Haleon plc (HLN) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Operating cash flow | $786.00M | $1.41B | $1.36B | $2.06B | $2.10B | $2.30B | $2.29B |
| Capital expenditures | $243.00M | $318.00M | $298.00M | $328.00M | $336.00M | $250.00M | $314.94M |
| Depreciation | $260.00M | $305.00M | $268.00M | $287.00M | $309.00M | $324.00M | — |
| Stock-based comp | $-261.00M | $-702.00M | $-376.00M | $61.00M | $88.00M | $102.00M | $86.00M |
| Free cash flow | $543.00M | $1.09B | $1.06B | $1.74B | $1.76B | $2.05B | $1.97B |
| Investing cash flow | $291.00M | $1.03B | $-33.00M | $-8.78B | $-134.00M | $528.00M | — |
| Financing cash flow | $-925.00M | $-2.44B | $-1.24B | $6.91B | $-1.57B | $-1.54B | — |
| Dividends paid | $1.15B | $2.37B | $1.15B | $2.68B | $388.00M | $570.00M | $598.59M |
| Share repurchases | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — |